isopulegol has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalaivani, K; Sankaranarayanan, C | 2 |
2 other study(ies) available for isopulegol and Alloxan Diabetes
| Article | Year |
|---|---|
Isopulegol Mitigates Hyperglycemia Mediated Oxidative and Endoplasmic Reticulum Stress in HFD/STZ Induced Diabetic Rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Catalase; Cyclohexane Monoterpenes; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Hyperglycemia; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipid Peroxides; Male; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2020 |
Modulatory effect of isopulegol on hepatic key enzymes of glucose metabolism in high-fat diet/streptozotocin-induced diabetic rats.
Topics: Animals; Antibiotics, Antineoplastic; Blood Glucose; Carbohydrate Metabolism; Cyclohexane Monoterpenes; Diabetes Mellitus, Experimental; Diet, High-Fat; Fructose-Bisphosphatase; Glucose-6-Phosphatase; Hexokinase; Hypoglycemic Agents; Insulin; Liver; Male; Rats; Rats, Wistar; Streptozocin | 2021 |